Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,161 hedge funds and large institutions have $73.7B invested in Celgene Corp in 2014 Q4 according to their latest regulatory filings, with 182 funds opening new positions, 394 increasing their positions, 460 reducing their positions, and 38 closing their positions.
379% more first-time investments, than exits
New positions opened: 182 | Existing positions closed: 38
21% more funds holding in top 10
Funds holding in top 10: 100 → 121 (+21)
18% more capital invested
Capital invested by funds: $62.2B → $73.7B (+$11.5B)
13% more funds holding
Funds holding: 1,031 → 1,161 (+130)
14% less repeat investments, than reductions
Existing positions increased: 394 | Existing positions reduced: 460
32% less call options, than puts
Call options by funds: $1.28B | Put options by funds: $1.88B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.52B |
| 2 |
UBS AM
Chicago,
Illinois
|
+$278M |
| 3 |
Polen Capital Management
Boca Raton,
Florida
|
+$167M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$126M |
| 5 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
+$126M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$245M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$224M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$217M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$189M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$154M |
CELG Hedge Fund Activity: Q4 2014 in Review
1,161 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2014, worth a combined $73.7B — up 18% from $62.2B a quarter earlier.
Buyers outnumbered sellers: 182 funds opened new CELG positions and 38 closed out — a net gain of 144 holders — while 394 added to existing stakes and 460 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $1.52B. The largest seller was JP Morgan Chase, cutting an estimated $245M.
- 1,161 institutional investors held Celgene Corp (CELG) as of Q4 2014, up from 1,031 in Q3 2014.
- Funds reported $73.7B of Celgene Corp stock for Q4 2014, up 18% quarter-over-quarter.
- 182 funds opened new Celgene Corp positions in Q4 2014 and 38 closed out, a net change of +144 holders.
- The largest Celgene Corp buyer in Q4 2014 was Fidelity Investments, an estimated $1.52B added.
- The largest Celgene Corp seller in Q4 2014 was JP Morgan Chase, an estimated $245M sold.
Based on aggregated 13F filings for Q4 2014.